Comments on: ‘Crosswalk’ Re-Launched to Make it Easier to Bridge the Gap Between Pathology, Precision Diagnosis and Precision Medicine https://tissuepathology.com/2017/02/20/crosswalk-re-launched-to-make-it-easier-to-bridge-the-gap-between-pathology-precision-diagnosis-and-precision-medicine/ Educational and informative Wed, 01 Mar 2017 13:17:46 +0000 hourly 1 By: Robson Tolson https://tissuepathology.com/2017/02/20/crosswalk-re-launched-to-make-it-easier-to-bridge-the-gap-between-pathology-precision-diagnosis-and-precision-medicine/#comment-153264 Wed, 01 Mar 2017 13:17:46 +0000 http://tissuepathology.com/?p=11468#comment-153264 As stated in the latest report published by Credence Research, Inc. “Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022.
Browse the full report Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at http://www.credenceresearch.com/report/liquid-biopsy-market

]]>